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Abstract 
Oral lichen planus (OLP) is an inflammatory disease that can be painful, 
mainly in the atrophic and erosive forms. Numerous drugs have been used 
with dissimilar results, but most treatments are empirical. However, to date, 
the most commonly employed and useful agents for the treatment of OLP are 
topical corticosteroids. The study objective was to detail the clinical 
effectiveness of low-level laser therapy (LLLT) for the management of OLP 
unresponsive to standard topical therapy. 
The authors studied a prospective cohort of 30 patients affected by OLP, who 
received biostimulation with a 980-nm gallium-aluminum-arsenide (GaAIAs) 
diode laser (DM980, distributed by DMT S.r.l., Via Nobel 33, 20035, Lissone, 
Italy). Outcome variables, statistically evaluated, were: the size of lesions; 
visual analogue score of pain and stability of the therapeutic results in the 
follow up period. 
Eighty-two lesions were treated. We reported significant reduction in clinical 
scores of the treated lesions and in reported pain. No detailed complications 
or therapy side effects were observed during the study. 
As previously reported by our group with a preliminary report, this study 
suggests that LLLT could be a possible treatment choice for patients with 
unresponsive symptomatic OLP, also reducing the possible invasiveness 
correlated with other therapies.  
 
 
 
Introduction 
Oral lichen planus (OLP) is a relatively common chronic inflammatory 
disease, of unknown aetiology, rarely undergoing spontaneous remission and 
potentially premalignant [1]. OLP is difficult to palliate and in several cases, 
most therapies are merely symptomatic [2]; even if the best treatment remains 
high-potency topical corticosteroids, management is usually empirical, without 
adequate control groups or corrected study designs [3].  
Low-Level Laser Therapy (LLLT) is an approach increasingly used in 
medicine, which has potential biostimulating effects also if applied to oral 
tissues by improving wound healing, enhancing epithelization after periodontal 
surgery, and preventing or healing induced oral mucositis [4-6]. Laser 
biostimulation can obtain different intracellular biological reactions to stimulate 
regenerative abilities, without undesired adverse effects, reducing also the 
pharmacological support and its possible invasiveness. Besides explaining 
many controversies in the field of low-power laser effects (i.e., the diversity of 
effects, the variable magnitude or absence of effects in certain studies), the 
proposed redox-regulation mechanism may be a fundamental explanation for 
some clinical effects of irradiation, for example the positive results achieved in 
treating wounds, chronic inflammation, and ischemia, all characterized by 
acidosis and hypoxia [7]. 
To date, few reports have been published describing the efficacy of laser 
irradiation in erosive oral mucosal diseases, such as mucous membrane 
pemphigoid [8-10], aphthous stomatitis [11, 12], OLP [13] and chronic 
lichenoid graft-vs.-host disease [14].  
The aim of this prospective study was to estimate the effects and the efficacy 
of LLLT on the outcome of unresponsive OLP, in term of clinical healing and 
pain control, on a prospective cohort of patients attending an oral medicine 
clinic. 
 
Patients and methods 
Consecutive Caucasian patients, attending the Oral Medicine Section of the 
Lingotto Dental School, Turin Hospital, Italy, from January 2009 and July 
2012, were selected for the present study. 
The inclusion criteria were: a) histological diagnosis of OLP on the basis of 
WHO criteria [15]; b) presence of painful and atrophic-erosive oral lesions, 
unresponsive to topical corticosteroid therapy (already and previously treated 
in our department); c) ability to complete the present clinical trial.  
The exclusion criteria were: a) presence of histological signs of dysplasia; b) 
use of lichenoid reaction inducing drugs; c) therapy for OLP in the 2 months 
prior to the study; d) pregnant or breast-feeding women. 
All patients were clinically evaluated by a skilled group of oral health care 
providers [A.C and P.G.A], who recorded the clinical aspect of the lesions, 
size and sites of oral involvement.  
Different treatment options were discussed with the patients, and they all 
submitted written informed consent before enrolment, which was carried out in 
accordance with the declaration of Helsinki.  
LLLT was delivered with a 980-nm gallium-aluminum-arsenide (GaAIAs) 
diode laser (DM980, distributed by DMT S.r.l., Via Nobel 33, 20035, Lissone, 
Italy). The device was used according to the manufacturer’s instructions. A 
collimated probe, with a diameter of 0.6 cm and a spot size of 0.28 cm2, was 
used.  The output power was 300 mW, verified using the calibrating door of 
the laser device, and the power density was about 1 W/cm2. A “spot” 
technique was used, with a slight overlapping in order to evenly distribute 
energy covering all the mucosal lesions and also the peri-lesional tissues up 
to 0.5 cm. 
Each session was performed delivering a fluence of 4 J/cm2 per lesion, and 
the probe was held perpendicularly at a distance of about 2 mm. The time of 
delivery per point of application was calculated using the formula t (time) = D 
(dose-fluence) x A (area of the spot) / P (output power). 
Therefore the calculations are: t (time) = 4 x 0,28/0,3 = 3,73 seconds in 
continuous wave. 
Each patient underwent one laser irradiation sessions weekly until the 
resolution of signs (e.g. the disappearance of all atrophic-erosive lesions, 
regardless of any persisting hyperkeratotic lesions).  
A single skilled examiner [A.C.] performed all the laser sessions, and another 
one [P.G.A.] recorded site and size of lesion, and reported pain. Clinical 
measurements were performed one week before the first laser procedure 
(T0), after each laser session, and 30-90-180 days after the resolution of 
signs, then every 6 months thereafter. Each patient was examined by means 
of record chart compilation, oral examination, registration of symptoms and 
clinical signs, and photo. The clinical data were scored according to the 
criteria scale used by Thongprasom and co-workers [16]: score 0: no lesions; 
score 1: hyperkeratotic lesions; score 2: atrophic area ≤ 1 cm²; score 3: 
atrophic area > 1 cm²; score 4: erosive area ≤  1 cm²; score 5: erosive area > 
1 cm². 
Complete response (total resolution of the clinical signs) was defined as the 
disappearance of all atrophic-erosive lesions, regardless of any persisting 
hyperkeratotic lesions; scores were either zero or one. Partial response, or 
persisting of the patient’s condition, meant a decrease (score 2, 3 or 4) or no 
change at all in the patient’s score. The difference between baseline and 
endpoint scores numerically expresses the clinical and symptomatic 
improvement. 
The symptoms score was obtained using a Visual Analogue Scale (VAS). The 
VAS consisted of a 10 cm-horizontal line marked 0 (= no pain) to 10 (= most 
severe pain ever experienced). Patients were requested to mark the scale at 
each visit, before and after laser session. Complete resolution of the 
symptoms (no symptoms) was defined as the absence of any discomfort, 
corresponding to a zero VAS score.  
The stability of the results in the follow up period was also described. 
Describing general information, data was reported as means and standard 
deviation (SD), unless otherwise described. Wilcoxon’s signed rank was used 
to calculate the significance of the outcome data for clinical score, whereas 
paired samples T-test to calculate difference in reported symptoms. P-values 
≤ 0.05 were considered to be statistically significant. SPSS (SPSS for 
windows, version 11, SPSS inc, Chicago, IL, USA) statistical software was 
utilized. 
 
Results 
A total of 30 patients took part in the study, of which 19 were women 
(63.33%); the mean age at presentation was 64.5 years (± 11.27).  
Seventeen patients had been previously treated with clobetasol propionate 
ointment 0.05% (Clobesol®, Glaxo, Verona, Italy), usually applied twice daily 
for at least 2 months; anti-mycotic treatment was also used as prophylaxis 
against oropharyngeal candidosis, consisting of miconazole gel (Micotef®, 
LPB, Cinisello B., Milano, Italy) applied once daily and 0.12% chlorhexidine 
mouth rinse (Plack-out®, BYK, Gulden Italia, Cormano, Milano, Italy) three 
times daily. The remain 13 patients did not receive any earlier treatment for 
oral ulcerations due to OLP.  
Eighty-two lesions were treated at the end of the protocol (10 with score 2; 20 
with score 3; 37 with score 4 and 15 with score 5). The different sites of 
involvement are reported in Table 1. The buccal mucosa was the most 
common site (52.7%), followed by the upper gingiva and the tongue. A 
complete resolution in clinical signs was obtained in 64 of the 82 lesions 
treated (78.05%) with a mean number of laser sessions of 11.79 (± 4.32). 
Moreover, a partial clinical response was found in 14 lesions (17.07%), with a 
mean number of laser sessions of 13.50 (± 3.91). Only 4 lesions (4.88%) had 
no change at all in the clinical characteristics, with a mean number of laser 
sessions of 12.7 (± 4.56) (Figure 1-2). The initial score, gender and age did 
not influence the results (data not shown). Considering the overall response 
for each case, 18 patients (60%) obtained a total resolution of the clinical 
signs, 10 patients (33.3%) a partial resolution and 2 patients (6.6%) did not 
respond at all. 
We calculated the clinical improvement as the difference of clinical score at 
baseline and at the end of the treatment, reporting significant statistical 
differences (P=0.003) (Figure 3). 
Sixty-five of the 82 treated patients (79.27%) had symptom improvements 
already after the first 4 sessions of therapy, with significant statistical 
differences (P=0.001) (Figure 4). 
Table 2 provides information about the total dose for session for every treated 
case. No reported complications or therapy side effects were observed in any 
of the patients treated. We also examined patient pain perception after each 
procedure, and the VAS score was 0 in all cases. 
The mean duration of follow-up was 26.6 months (± 6.38). During the follow-
up period, 15 patients (50%) did not show new atrophic-erosive lesions. 
 
Discussion 
Nowadays, among many treatments accessible, high potency corticosteroids 
remain the most reliable and effective modality for the therapy of symptomatic 
OLP. For instance, clobetasol propionate appeared to be one of the most 
effective topical steroids, as in an adhesive base led to complete remission in 
56-75% of patients [17-19]. Unfortunately, some patients are refractory to 
topical corticosteroids.  
As previously reported, LLLT is a newly approach increasingly used in 
medicine, which has potential biostimulating effects also if applied to oral 
tissues. It is unclear how LLLT works; it has been suggested to reduce  
inflammation by lowering, in a dose-dependent manner, levels of 
prostaglandin E2,  prostaglandin-endoperoxide synthase 2,  interleukin 1 
beta, tumour necrosis factor-alpha, the cellular influx of neutrophil 
granulocytes, oxidative stress, edema, and bleeding;  other mechanism may 
be related to stimulation of mitochondrion to increase the production 
of adenosine triphosphate, resulting in an increase in reactive oxygen 
species, which influences redox signalling, affecting 
intracellular homeostasis or the proliferation of cells [20, 21].  
Some recent evidence suggests that LLLT would currently appear to be a 
possible treatment for some patients with different type of oral erosive lesions, 
guaranteeing an immediate and notable analgesic effect [8-14]. In particular, 
in a preliminary report our group reported that LLLT appeared to be a possible 
treatment for some patients with OLP and can be used as an alternative 
therapy alongside standard treatment methods, especially for unresponsive 
patients [13]. Nonetheless controversies about tissues biostimulating with 
LLLT still remain and missing of homogeneous reporting of physical and 
biological variables makes summing up of the results particularly difficult.  
Our findings might have a significant clinical impact since LLLT is easy to 
perform, but does not increase morbidity or presents side effects. 
Before starting this study, we reported some preliminary data about LLLT for 
olp patients in which most of the patients reported an immediate pain relief 
after the first sitting, and all of them reported a complete resolution of 
symptoms at the end of the laser sessions, even if some lesions had only a 
partial clinical response [13]. For those cases, we initially used a 904-nm 
pulsed infrared laser (4 J/cm2 energy density per minute, spot size 0.8 cm); in 
this new prospective study we decided to deliver the same energy density 
using a 980-nm gallium-aluminum-arsenide (GaAIAs) diode laser that has a 
more superficial action, from an optical point of view if compared to 810 nm 
and to 904 nm [22], and this could be more useful for managing atrophic-
erosive oral lesions, also possibly explaining the better results reported in this 
new group of patients. 
We showed a statistical significance in the different of clinical scores after 
laser treatment. Only 4 lesions (4.88%) had no change at all in the clinical 
characteristics. Similar to previous limited published data, the number of laser 
sessions necessary for the tissues to heal was different, in relation to the 
characteristics of the lesions; the gingiva seemed to be more resistant but 
without statistical significance (data not shown). Usually, the clinical remission 
was obtained in a period of approximately 5 to six week; if the lesions do not 
show any clinical improvement after 6 to 8 laser sessions, this means that that 
type of patient does not respond clinically.  
More than resolution of clinical scores, in this new series, pain score had a 
highly statistical improvement, quickly improving the quality of life of patients, 
even in the absence of complete resolution of all oral signs. 
In conclusion, this study confirmed our previously data; LLLT appears to be a 
possible treatment for OLP patients and a diode laser seems to be the more 
effective wave length. To date, no data are available comparing LLLT with 
standard therapies, and it could be interesting in the future to test this 
statement, also if considering that it is a minimally invasive therapy and that 
invasiveness is not an absolute concept, depending on many factors such as 
age, illness, disability and/or psychological conditions [23]. 
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